ProCE Banner Activity

Evolving Salvage Systemic Therapy in Metastatic Renal Cell Carcinoma in 2021

Slideset

Download these slides from a live webinar for the most recent data on how to sequence salvage therapy for patients with advanced RCC, including a look at novel treatment options currently in clinical trials.

Released: June 16, 2021

Expiration: June 15, 2022

Share

Faculty

Neeraj Agarwal

Neeraj Agarwal, MD

Professor of Medicine
Senior Director for Clinical Research, Huntsman Cancer Institute (HCI)
Presidential Endowed Chair of Cancer Research
Director, Center of Investigational Therapeutics
Director, Genitourinary Oncology Program
Huntsman Cancer Institute, University of Utah (NCI-CCC)
Salt Lake City, Utah

Provided by

Provided by the National Comprehensive Cancer Network in collaboration with Clinical Care Options, LLC

ProCE Banner

Supporters

Supported by educational grants from

Eisai

Exelixis, Inc.

Merck Sharp & Dohme Corp.

Faculty Disclosure

Primary Author

Neeraj Agarwal, MD

Professor of Medicine
Senior Director for Clinical Research, Huntsman Cancer Institute (HCI)
Presidential Endowed Chair of Cancer Research
Director, Center of Investigational Therapeutics
Director, Genitourinary Oncology Program
Huntsman Cancer Institute, University of Utah (NCI-CCC)
Salt Lake City, Utah

Neeraj Agarwal, MD, FASCO, has no relevant financial relationships to disclose.